Photo Credit: iStock.com/CristiNistor

The emerging use of ultrasound in TD offers a promising, noninvasive tool for earlier detection, targeted treatment, and improved patient outcomes.

Tardive dyskinesia (TD) is a movement disorder commonly associated with long-term use of dopamine receptor-blocking agents, such as antipsychotics. Characterized by involuntary, repetitive movements, TD can affect multiple areas of the body, including the face, tongue, and limbs. Diagnosing TD, particularly when involving subtle oropharyngeal and lingual movements, presents challenges due to its varied manifestations. 

Traditional diagnosis relies on clinical observation, but subtle dystonic movements, especially in the tongue and pharyngeal muscles, can go unnoticed. Standard imaging techniques such as MRI often fail to capture dynamic movement abnormalities. Electromyography (EMG), though useful, is invasive and may not always reproduce the dystonic contractions observed in TD patients. These diagnostic challenges contribute to treatment delays and mismanagement, exacerbating patient distress and functional impairment. Incorporating novel imaging methods like ultrasound could enhance detection and improve clinical outcomes.

The Emerging Role of Ultrasound and Clinical Guidelines

A recent case series highlights the potential role of ultrasound in detecting and characterizing these often-missed presentations of TD, offering a valuable addition to the diagnostic toolkit for clinicians. Current clinical guidelines emphasize the importance of early detection and management of TD, particularly by assessing patients on chronic dopamine-blocking therapy. The American Academy of Neurology recommends tools like the Abnormal Involuntary Movement Scale (AIMS) for systematic monitoring. However, these guidelines primarily focus on visible dyskinetic movements, with limited emphasis on detecting movements that occur when the mouth is closed or within the pharyngeal region. The emerging use of ultrasound as a diagnostic aid aligns with expert calls for improved, noninvasive imaging modalities in neurology. Point-of-care ultrasound (POCUS) allows for dynamic visualization of lingual and pharyngeal muscle contractions, making it a promising tool for more accurate diagnosis. Expanding ultrasound’s role in movement disorders could refine current diagnostic protocols and facilitate earlier intervention.

Barriers to Implementation and Potential Solutions

One of the primary barriers to TD diagnosis is the reliance on clinical observation, which may fail to detect movement abnormalities in less accessible anatomical regions. Additionally, traditional imaging methods are not designed to capture real-time muscle activity. To integrate ultrasound into TD evaluation, standard training protocols for neurologists and movement disorder specialists must be developed. Further research is needed to establish sonographic criteria for TD diagnosis, ensuring consistent interpretation of findings across clinical settings. Increased access to ultrasound equipment and familiarity with its use in neurology could facilitate broader adoption in routine practice. Widespread adoption would require clinician education, as well as demonstrating cost-effectiveness and clinical utility in larger studies.

Treatment Advancements and Ultrasound-Guided Interventions

Management of TD involves discontinuation or dose reduction of causative agents when feasible, along with pharmacologic and interventional treatments. The FDA has approved vesicular monoamine transporter 2 (VMAT2) inhibitors, such as valbenazine and deutetrabenazine, as first-line pharmacologic therapies. Additionally, botulinum toxin injections have shown promise in focal dystonias. In the case series, ultrasound played a crucial role in guiding botulinum toxin injections to the precise affected muscles, leading to significant symptom improvement. This approach offers a more targeted and effective treatment strategy compared to conventional empirical dosing, potentially reducing side effects and improving patient outcomes. Ultrasound-guided interventions could become a preferred approach for patients with complex TD presentations.

Patient Education and Clinical Integration

Patient education is vital in managing TD, as many individuals may not recognize the link between their medications and movement symptoms. Clinicians should counsel patients on the risk factors for TD and the importance of regular monitoring. For those undergoing ultrasound-guided interventions, clear communication regarding the procedure, expected outcomes, and follow-up is essential to ensure adherence and optimal results. As research progresses, the incorporation of ultrasound into routine clinical practice may revolutionize TD management, offering improved outcomes for patients with this often-debilitating condition. Ensuring accessibility and proper clinician training in ultrasound techniques will be key to its successful integration into standard TD care.